The London Stock Exchange uses cookies to improve its website. The cookies for analytical purposes have already been set. For more details and how to manage cookies, please see our privacy and cookies policy.


 Page 2 of 4

Previous | 1 | 2 | 3 | 4 | Next

Time/Date Code Headline Source Impact
10:42 31-Dec-2015 GWP TOTAL ISSUED SHARE CAPITAL RNS -1.00% Down
14:26 29-Dec-2015 GWP Director/PDMR Shareholding RNS +2.44% Up
12:00 24-Dec-2015 GWP Lancet Neurology Publishes Epidiolex Data RNS +5.00% Up
17:14 22-Dec-2015 GWP Director/PDMR Shareholding RNS -0.01% Down
18:22 21-Dec-2015 GWP Director/PDMR Shareholding RNS -2.65% Down
16:16 16-Dec-2015 GWP Director/PDMR Shareholding RNS -10.68% Down
09:27 16-Dec-2015 GWP Director/PDMR Shareholding RNS -10.68% Down
07:00 08-Dec-2015 GWP Final Results RNS -9.80% Down
21:00 07-Dec-2015 GWP GW Pharmaceuticals plc Reports Fourth Quarter and Year-End 2015 Financial Results and Operational Progress ONE -7.74% Down
18:00 07-Dec-2015 GWP New Physician Reports of Epidiolex Treatment RNS -7.74% Down
13:00 30-Nov-2015 GWP Date and Time Change for Q4 and FY 2015 Results RNS +3.16% Up
09:38 30-Nov-2015 GWP Total Voting Rights RNS +3.16% Up
14:00 25-Nov-2015 GWP Epidiolex data to be presented at AES Meeting RNS +2.23% Up
18:00 24-Nov-2015 GWP Notice of Results RNS +1.66% Up
18:00 24-Nov-2015 GWP Presenting at Piper Jaffray Healthcare Conference RNS +1.66% Up
10:09 02-Nov-2015 GWP Total Voting Rights RNS +4.07% Up
11:05 27-Oct-2015 GWP Agreement with NSW to Study Epidiolex and CBDV RNS -3.96% Down
11:00 27-Oct-2015 GWP Results from Sativex Phase 3 Cancer Pain Trials RNS -3.96% Down
14:00 15-Sep-2015 GWP Positive Proof of Concept Data in Schizophrenia RNS +7.13% Up
14:00 10-Sep-2015 GWP Presenting at Two Upcoming Investor Conferences RNS +3.01% Up

 Page 2 of 4

Previous | 1 | 2 | 3 | 4 | Next

Price changes are calculated on the basis of the following formula: [ avg(x) - avg(y)] / avg(y) where:
x = instrument's 7 closing prices after the news has been released
y = instrument's latest 7 closing prices before the news was released, including the day of the release of the news

Please note that the news releases are only one of the multiple factors that could have had an impact on the change in the security’s price over the time period analysed by the News Analysis tool. Where data are insufficient the graph does not show any price change and the table below the graph displays a blank “ - “ next to the line indicating the RNS issue.


Company Information
Updated Monthly
Company address Porton Down Science Park, Salisbury, SP4 0JQ, United Kingdom
Company website
Market cap(in millions)* £ 1,189.84
Listing/Admission to trading 28 Jun 2001
Trading service SETS
Market AIM
Listing category -
*The market capitalisation of companies reflects the London listed element only. These figures are approximate and are updated monthly.

Trading Information
FTSE index FTSE AIM All-Share,FTSE AIM 100,FTSE AIM UK 50,FTSE AIM All-Share - Health Care
FTSE sector Pharmaceuticals & Biotechnology
FTSE sub-sector Pharmaceuticals
Country of share register GB
Segment AMSM
MiFID Status MTF
Exchange market size 3,000
SEDOL 3054468
ISIN number GB0030544687

Start trading your favourite asset CFDs!
Carries risk of capital loss

GW PHARM. share news analysis (GWP)